DAVID SNOW: Open Payments
NPI 1821096041 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,477 in 110 payments from 15 companies in 2025. Trend: 2023 $134,798 · 2024 $65,924 · 2025 $45,477
Speaker / faculty: $40,040Consulting: $2,090Travel & lodging: $1,763Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 57 | $44,515 |
| Neurocrine BioSciences, Inc. | 9 | $199 |
| Axsome Therapeutics, Inc. | 19 | $191 |
| Vanda Pharmaceuticals Inc. | 4 | $146 |
| Janssen Pharmaceuticals, Inc | 3 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Alkermes, Inc. | 4 | $77 |
| Lundbeck LLC | 2 | $37 |
| Corium, LLC | 1 | $34 |
| Sage Therapeutics, LLC | 2 | $32 |
Products named: CAPLYTA, INGREZZA, Auvelity, HETLIOZ, SPRAVATO, AUSTEDO XR, LYBALVI, ARISTADA.
Industry payments across TN — which companies pay providers there.
